Watch the best movies ever, watch ESPN 360
>>>WATCH ON MY MYSPACE NOW<<<
Serbian Internet Radio, OLD Serbian music.
Naked Survey...
Q: Where are you now?
Britney: Crazy - Stop Remix!
Q: My only wish?
Britney:Born to Make you hapy!
Q:Toxic?
Britney:Breathe on me!
Q: Lonely?
Britney::Deep in my heart!
Q:Do somethin?
Britney:I can't get no Satisfaction!
Q:Crazy?
Britney:I got that!
Q:Miss Spears?
Britney:Right now!
Q:My only wish?
Britney:Oops!...I Did it Again!
Q:From the Bottom of my Broken Heart...
Britney:Don't Hang Up! Can't Make You Love me?
Q:Do something!
Britney:I'm not a Girl, not yet a Womman!
Q:Outrageous!
Britney:One kiss from you?
Q:Right now?
Britney:Slave 4 u!
Q:When your eyes say it!
Britney:What you see is what u get!
Q:Overprotected?
Britney:Lucky!
Q:Anticipating?
Britney:Boys!
Q:The Hook up VS Soda POP...
Britney:The joy of Pepsi...
I love rock & Roll so E-mail my Heart!
NEW YORK–Britney Spears entered rehab yesterday after a bizarre weekend that included shaving her head and getting a new tattoo. Meanwhile, the salon where she shaved her head has set up a website to sell her hair and other items.
Spears's manager, Larry Rudolph, told People magazine's website that Spears, 25, had voluntarily checked herself into an undisclosed treatment facility.
"We ask that the media respect her privacy as well as those of her family and friends at this time," Rudolph said.
CONTACT GROUP MEETING
(Paris, 14th February 1999)
Chairman's Conclusions
|
Réunion du Groupe de contact
(Paris, le 14 février 1999)
Conclusions de la Présidence
Nous réaffirmons l'entier soutien du Groupe de contact à nos trois négociateurs. Nous faisons nôtre leur détermination d'intensifier le rythme des négociations afin que celles-ci aboutissent d'ici à une semaine au plus tard. Les deux co-présidents, MM.Hubert Védrine et Robin Cook, ont réaffirmé leur disponibilité à retourner à Rambouillet, chaque fois que cela nécessaire, afin d'aider les négociateurs à faire progresser les négociations. |
The Food and Drug Administration on Wednesday approved the first diet drug to be sold without a prescription.
The drug is a lower-dose version of the prescription medicine Xenical and will become available to consumers this summer under the name alli.
The pill will be marketed to people over 18 and will compete against nutritional supplements, which do not require FDA approval and the rigorous safety and efficacy testing that entails.
GlaxoSmithKline, the marketer of alli, said the drug would retail at $2 to $3 for a day's dose. The company expects 5 million to 6 million people to try the drug during its first year on the market.
Dr. Charles J. Ganley, FDA director of nonprescription products, said consumers should use the pill as part of a diet and exercise program. Used alone, it "is unlikely to be beneficial," he said at a news briefing.
Dr. Adrienne Youdim, a weight loss specialist at Cedars-Sinai Medical Center, said alli, also known by its generic name orlistat, has a good safety record and has helped people lose an average of 10 to 16 pounds.
The chief drawback of the pill, Youdim said, is that it can cause flatulence and greasy stools. However, those side effects also prevent people bent on losing weight from abusing alli, Youdim said.
Madelyn Fernstrom, a weight loss specialist at the University of Pittsburgh Medical Center, cautioned that alli was not a magic bullet. "Just because it's FDA-approved for over-the-counter weight control doesn't mean it is going to work for everybody," she said.
Fernstrom said people who used the pill must be willing to exercise and reduce their total calorie intake to see meaningful results.
Dr. Sidney Wolfe, director of health research at the watchdog group Public Citizen, said that the drug could cause precancerous lesions of the colon and that the FDA should not have cleared it for nonprescription use.
But Steven L. Burton, Glaxo vice president for weight control products, said orlistat had been tested in 30,000 patients in 100 clinical trials for up to four years "with no cause for concern."
The FDA's approval of alli is another sign that the drug is safe, he said.
"This is the most extensively studied weight loss medicine in the world," Burton said.
The approval of alli comes amid increasing concerns about obesity. About 130 million Americans are considered overweight, and nearly 50% of those are obese.
Glaxo estimated that Americans spent $23 billion annually on weight loss products, including $1 billion on nutritional supplements.
Alli will be available at half the strength of Xenical but will have a similar effect on weight loss, according to the company.
Xenical was approved for sale as a prescription drug in 1999, but it was not highly successful, with U.S. sales peaking around $200 million in 2000.
Sales suffered because few insurance plans covered the drug, and obese people, the chief market for the prescription product, were not satisfied with the small amount of weight they lost.
Dr. Peter LePort, a weight loss specialist at Orange Coast Memorial Hospital in Fountain Valley, said alli would appeal to people who want to lose a modest amount of weight without going to a doctor for a prescription.
"There is a whole segment of society looking to lose 10 to 20 pounds," he said.
Aussie wins race up Empire State Building
NEW YORK: Australian Suzy Walsham took up staircase running to win a trip to New York, and has captured the top prize after racing 1576 steps up the city's tallest skyscraper at the Empire State Building Run-Up.
Walsham broke the tape on the 86th-floor Observation Deck in 13 minutes, 12 seconds to beat American Cindy Moll-Harris, a four-times winner of the event, by 12 seconds.
Germany's Thomas Dold won his second successive race up the landmark building by 31 seconds over compatriot Jahn Mattias with a time of 10:25, to take the men's title. It was the 30th time the annual event had been run.
"I'm a novice. I'm a newcomer," said a beaming Walsham, a former Australian 1500 metres champion.
"I did my first stairway race last November in Singapore," said the Sydney native, who now works as an accountant in Singapore. "And I did it because the prize was a trip to come here. This is only my second stairs race ever."
Walsham, 33, said she has been running 80km per week. She improvised some training last week for the Empire race, which awards a trophy but no prize money.
"My Singapore condominium is 17 stories high and I live on the fifth floor, which is my only access to the stairwell," she said. "So I ran to the top, caught the lift back down and did that eight times. I did that twice before I came here.
The Australian said she was surprised how easily it went.
"It didn't hurt as much as I thought it would, but a couple of minutes after I finished I started getting chest pains and I felt like I was going to throw up.
"And I thought 'I can't do that here in front of everyone!' Fortunately, I didn't."
There were 200 finishers in the race, 145 men and 55 women. The competitions, from 12 countries, climbed 320 metres.
Walsham said she was pleased to carry on the Empire success of Australian cyclist Paul Crake, who from 1999 won five successive sprints up the building. Crake was paralysed by a cycling accident last November in New Zealand.
"Australia has quite a good tradition here and it's an absolute tragedy the injury that Paul Crake had. So I'm thrilled to have kept up that tradition," she said.
Walsham won three days accommodations in New York with her Singapore victory, and has decided to stay on the rest of the week out of her own pocket.
Dold, however, was in a rush after his stairs sprint.
The 22-year-old said he was hurrying back to university in Stuttgart for a course in farming economics at noon on Wednesday.